DV Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$371K Sell
2,351
-4,994
-68% -$788K 0.01% 312
2026
Q2
$1.16M Sell
7,345
-6,729
-48% -$910K 0.04% 133
2026
Q1
$1.8M Buy
14,074
+12,673
+905% +$1.58M 0.04% 121
2025
Q4
$171K Buy
+1,401
New +$161K ﹤0.01% 237

Other funds holding XBI

DV Trading's XBI Position: Q3 2026 in Review

DV Trading reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 68% in Q3 2026, selling an estimated $788K and leaving 2,351 shares worth $371K. The position accounts for 0.01% of the portfolio, ranked #312.

DV Trading first reported a position in XBI in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.8M in Q1 2026. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • DV Trading held 2,351 shares of State Street SPDR S&P Biotech ETF worth $371K as of Q3 2026.
  • DV Trading sold 4,994 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $788K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of DV Trading's portfolio in Q3 2026, its #312 holding.
  • DV Trading first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 4 quarters since.
  • DV Trading's State Street SPDR S&P Biotech ETF position peaked at $1.8M in Q1 2026.
  • 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on DV Trading's 13F filing for Q3 2026, filed 16 Nov 2026.